Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
Active, not recruiting · Not applicable · NCT02489539
Conditions: Aortic Aneurysm, Abdominal
At a glance
- Research payments reported, 2025
- $45,322
- U.S. investigators named
- 20
- Sites paid
- 18
- Planned or actual enrollment
- 175
About the trial
- Sponsor
- W.L.Gore & Associates
- Tested
- GORE® EXCLUDER® Conformable AAA Endoprosthesis (device)
- Dates
- Started 2017-12-19; completion 2027-12-31
- Results posted
- Yes
The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.
From ClinicalTrials.gov, last updated 2025-08-13. Full record, eligibility and contacts (opens in a new tab)
Industry funding
W. L. Gore & Associates, Inc. reported $45,322 in research payments for this study in 2025 (30 payments).
Products named: Gore Excluder Aaa Endoprosthesis, Product in Development, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Cardioform Septal Occluder
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Victor Davila, MD, RPVI Vascular Surgery · Phoenix, AZ
- Sukgu M. Han, M.D. Vascular Surgery · Los Angeles, CA
- Melhem J. Sharafuddin, MD Vascular Surgery · Colorado Springs, CO
- Martin Back, MD Vascular Surgery · Tampa, FL
- Alex Powell, MD Interventional Radiology · Miami, FL
- William P. Robinson, M.D. Vascular Surgery · Springfield, IL
- Waldemar C. Sternbergh III, MD Vascular Surgery · New Orleans, LA
- Jonathan L. Eliason, M.D. Vascular Surgery · Ann Arbor, MI
- M A. Mansour, MD Vascular Surgery · Grand Rapids, MI
- Jill J. Colglazier, M.D. Vascular Surgery · Rochester, MN
- Elliot J. Stephenson, M.D. Vascular Surgery · Minneapolis, MN
- Zachary J. Wanken, MD Vascular Surgery · Saint Louis, MO
- Bjoern D. Suckow, M.D. Vascular Surgery · Lebanon, NH
- Christopher J. Smolock, M.D. Vascular Surgery · Astoria, NY
- Patrick E. Muck, MD Vascular Surgery · Cincinnati, OH
- Jon G. Quatromoni, MD, MS Vascular Surgery · Cleveland, OH
- Sagar S. Gandhi, MD Vascular Surgery · Greenville, SC
- David J. Dexter II, MD Vascular Surgery · Norfolk, VA
- Paul D. Dimusto, M.D. Vascular Surgery · Madison, WI
- Shadi J. Abu-halimah, MD Vascular Surgery · Charleston, WV
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University of Iowa Hospital & Clinics, IA $10,450
- Mayo Clinic $6,205
- Mary Hitchcock Memorial Hospital, NH $4,462
- Sentara Medical Group $4,050
- University of Michigan Health System, MI $3,552
- University of Florida $3,050
- Good Samaritan Hospital, OH $2,830
- University of Wi Hospitals & Clinics Authority, WI $2,432
- Cleveland Clinic Foundation $1,430
- Charleston Area Medical Center Health Education and Research Institute $1,390
- Minneapolis Heart Institute Foundation $1,254
- Spectrum Health, MI $1,200
- Siu School of Medicine $1,000
- Prisma Health Greenville Memorial Hospital, SC $500
- Washington University School of Medicine $500
- University of Southern California $500
- Bcvi Research Department $390
- Ochsner Medical Center Acute, LA $128
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.